Nevertheless, enhanced T-ALL development was observed only in Ripk3−/− mice and not in Mlkl−/− mice, suggesting that the tumor-repressive activity of Ripk3 is primarily independent of Mlkl-mediated HSC elimination. The gene discussed is MLKL; the disease is acute lymphoblastic leukemia.